Ticker Launch
Sign inTry it free

SPAC · Merger completed

Vickers Vantage Corp. I

Business combination with Scilex Holding Company

Vickers Vantage Corp. I is a blank-check company (SPAC) that raised $120M in its initial public offering on Jan 8, 2021, listing on Nasdaq Capital Market. It completed its business combination with Scilex Holding Company on Nov 10, 2022; the combined company is Scilex Holding Company (SCLX). Graubard Miller advised the SPAC and Loeb & Loeb advised the underwriters on the IPO.

Scilex Holding Company, a majority-owned subsidiary of Sorrento Therapeutics, develops and commercializes non-opioid pain management products for acute and chronic pain. Its commercial product is ZTlido, a prescription lidocaine topical system.

Status
Merger completed
IPO date
Jan 8, 2021
IPO size
$120M
IPO exchange
Nasdaq Capital Market
Target
Scilex Holding Company (Legacy Scilex)
Announced
Mar 21, 2022
Closed
Nov 10, 2022
Combined company
Scilex Holding Company (SCLX)
SPAC counsel (IPO)
Graubard Miller and Maples and Calder
Underwriters' counsel (IPO)
Loeb & Loeb

More on this SPAC for subscribers

Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.

Try it free for 7 daysOpen in Ticker Launch

Then $99/month or $999/year. Cancel anytime.

Filings

Other deSPACs that closed in 2022